Cover image of the article: Central Nervous System Toxicity After Botulinum Neurotoxin Injection

Image Credit:Anesth Pain Med

Central Nervous System Toxicity After Botulinum Neurotoxin Injection

Authors

Yashar Ilkhchoui1,*, Ramsis F. Ghaly2, N. Nick Knezevic2, Kenneth D Candido2

Abstract

Since Its first description of botulism toxicity in 1820s, specific formulations of botulinum neurotoxin (BoNT) have been introduced with different clinical benefits. However, there is increasing number of adverse events reported to Food and Drug Administration. This report presents the case of 62-year-old woman with Parkinsons disease who received BoNT injections to treat painful spasticity in her hands. She developed severe generalized dystonia shortly after BoNT injections.

Highlights

How to Cite:Ilkhchoui Y, Ghaly RF, Knezevic NN, Candido KD. Central Nervous System Toxicity After Botulinum Neurotoxin Injection. Anesth Pain Med. 2013;3(1):. doi: https://doi.org/10.5812/aapm.9356

Full Text

Full text is available in PDF

Copyright

© 2013, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Similar Articles

27
Mar
2024
Paresis Following Type A Botulinum Toxin (Dysport) Injection: A Case Report

Paresis Following Type A Botulinum Toxin (Dysport) Injection: A Case Report

Sara Salarian,
Masoomeh Raoufi,
Sogol Asgari,
Faranak Behnaz,
Behnam Safarpour Lima

Salarian S, Raoufi M, Asgari S, Behnaz F, Safarpour Lima B. Paresis Following Type A Botulinum Toxin (Dysport) Injection: A Case Report. J Cell Mol Anesth. 2024;9(2):e146536. doi: https://doi.org/10.5812/jcma-146536

26
Sep
2011
Efficacy of Botulinum Toxin Type A for Treating Chronic Low Back Pain

Efficacy of Botulinum Toxin Type A for Treating Chronic Low Back Pain

Seyed M. Jazayeri,
Alireza Ashraf,
Habib M. Fini,
Hajar Karimian,
Mohamadreza V. Nasab

Jazayeri SM, Ashraf A, Fini HM, Karimian H, Nasab MV. Efficacy of Botulinum Toxin Type A for Treating Chronic Low Back Pain. Anesth Pain Med. 2011;1(2):77-80. doi: https://doi.org/10.5812/kowsar.22287523.1845

30
Jun
2016
Complications of Botulinum Toxin-A Injection in an Iranian Population

Complications of Botulinum Toxin-A Injection in an Iranian Population

Marzieh Afrozandeh,
Amir Heydariyan,
Zahra Azizian

Afrozandeh M, Heydariyan A, Azizian Z. Complications of Botulinum Toxin-A Injection in an Iranian Population. J Skin Stem Cell. 2017;4(2):e63334. doi: https://doi.org/10.5812/jssc.63334

12
Jan
2025
Botulinum Toxin Injection for Treating Spasticity in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis

Botulinum Toxin Injection for Treating Spasticity in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis

Seyede Zahra Emami Razavi,
Mohaddeseh Azadvari,
Omid Mirmosayyeb,
Saeed Vaheb,
Mahsa Ghajarzadeh,
Alireza Teymouri
,et al.

Emami Razavi SZ, Azadvari M, Mirmosayyeb O, Vaheb S, Ghajarzadeh M, et al. Botulinum Toxin Injection for Treating Spasticity in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis. Middle East J Rehabil Health Stud. 2025;12(2):e156825. doi: https://doi.org/10.5812/mejrh-156825

19
Feb
2024
Effect of Botulinum Toxin Type-A on Improvement of Muscle Function of Lower Limb in Children with Spastic Cerebral Palsy

Effect of Botulinum Toxin Type-A on Improvement of Muscle Function of Lower Limb in Children with Spastic Cerebral Palsy

Hamidreza Hematti,
Shahrzad Izadi,
Amir Molaei

Hematti H, Izadi S, Molaei A. Effect of Botulinum Toxin Type-A on Improvement of Muscle Function of Lower Limb in Children with Spastic Cerebral Palsy. J Microbiota. 2023;1(1):e143022. doi: https://doi.org/10.5812/jmb-143022

More by these authors

Yashar IlkhchouiPubMedScholar
Ramsis F. GhalyPubMedScholar
N. Nick KnezevicPubMedScholar
Kenneth D CandidoPubMedScholar
Share
Cited by
Metrics
Indexed in